421 related articles for article (PubMed ID: 17656116)
21. Porin-incorporated liposome induces Toll-like receptors 2- and 6-dependent maturation and type 1 response of dendritic cell.
Banerjee P; Biswas A; Biswas T
Int Immunol; 2008 Dec; 20(12):1551-63. PubMed ID: 18931363
[TBL] [Abstract][Full Text] [Related]
22. Novel mechanisms of suppressor activity exhibited by cytotoxic regulatory T cell lines, HOZOT.
Suzuki M; Sugimoto A; Harashima A; Otani T; Yamamoto M; Nakamura S; Yamasaki F; Nishiyama M; Okazaki Y; Kibata M
Exp Hematol; 2009 Jan; 37(1):92-100. PubMed ID: 19013006
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells.
Liu G; Zhao Y
Immunology; 2007 Oct; 122(2):149-56. PubMed ID: 17848162
[TBL] [Abstract][Full Text] [Related]
24. Tumor-specific dendritic cells generated by genetic redirection of Toll-like receptor signaling against the tumor-associated antigen, erbB2.
Xu Y; Darcy PK; Kershaw MH
Cancer Gene Ther; 2007 Sep; 14(9):773-80. PubMed ID: 17599092
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.
Driessens G; Gordower L; Nuttin L; Stordeur P; Blocklet D; Egrise D; Velu T; Bruyns C
Cancer Immunol Immunother; 2008 Dec; 57(12):1745-56. PubMed ID: 18369621
[TBL] [Abstract][Full Text] [Related]
26. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance.
Dubois B; Joubert G; Gomez de Agüero M; Gouanvic M; Goubier A; Kaiserlian D
Gastroenterology; 2009 Sep; 137(3):1019-28. PubMed ID: 19345221
[TBL] [Abstract][Full Text] [Related]
27. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of interleukin-10 signaling in lung dendritic cells by toll-like receptor 4 ligands.
Jose P; Avdiushko MG; Akira S; Kaplan AM; Cohen DA
Exp Lung Res; 2009 Feb; 35(1):1-28. PubMed ID: 19191102
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
30. Innate and adaptive immune pathways to tolerance.
Thornton CA; Morgan G
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
[TBL] [Abstract][Full Text] [Related]
31. Regulatory T cells and cancer.
Wang HY; Wang RF
Curr Opin Immunol; 2007 Apr; 19(2):217-23. PubMed ID: 17306521
[TBL] [Abstract][Full Text] [Related]
32. Innate immune functions of human gammadelta T cells.
Beetz S; Wesch D; Marischen L; Welte S; Oberg HH; Kabelitz D
Immunobiology; 2008; 213(3-4):173-82. PubMed ID: 18406365
[TBL] [Abstract][Full Text] [Related]
33. Effector/memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity.
Lin YC; Chang LY; Huang CT; Peng HM; Dutta A; Chen TC; Yeh CT; Lin CY
J Immunol; 2009 May; 182(10):6095-104. PubMed ID: 19414761
[TBL] [Abstract][Full Text] [Related]
34. Using signaling pathways to overcome immune tolerance to tumors.
Engleman EG; Brody J; Soares L
Sci STKE; 2004 Jul; 2004(241):pe28. PubMed ID: 15252217
[TBL] [Abstract][Full Text] [Related]
35. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance.
Yang Y; Huang CT; Huang X; Pardoll DM
Nat Immunol; 2004 May; 5(5):508-15. PubMed ID: 15064759
[TBL] [Abstract][Full Text] [Related]
36. Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer.
Wang RF
Semin Cancer Biol; 2006 Feb; 16(1):73-9. PubMed ID: 16140545
[TBL] [Abstract][Full Text] [Related]
37. Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.
Lizée G; Radvanyi LG; Overwijk WW; Hwu P
Clin Cancer Res; 2006 Aug; 12(16):4794-803. PubMed ID: 16914564
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cells and toll-like receptors in cancer therapy.
Wang RF
Cancer Res; 2006 May; 66(10):4987-90. PubMed ID: 16707417
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptors on regulatory T cells: expanding immune regulation.
Sutmuller RP; Morgan ME; Netea MG; Grauer O; Adema GJ
Trends Immunol; 2006 Aug; 27(8):387-93. PubMed ID: 16814607
[TBL] [Abstract][Full Text] [Related]
40. TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis.
King CG; Kobayashi T; Cejas PJ; Kim T; Yoon K; Kim GK; Chiffoleau E; Hickman SP; Walsh PT; Turka LA; Choi Y
Nat Med; 2006 Sep; 12(9):1088-92. PubMed ID: 16921377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
